CVR number 13671087
Industry 20.5900 Manufacture of other chemical products n.e.c.

NYMANN KEMI A/S

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  3.1% 2.2% 4.0% 2.5% 1.5%  
Credit score (0-100)  58 66 48 62 75  
Credit rating  BBB BBB BBB BBB A  
Credit limit (kDKK)  0.0 0.4 0.0 0.0 17.1  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  0 0 0 0 0  
Gross profit  200 450 335 236 1,456  
EBITDA  -115 140 3.0 -20.8 1,396  
EBIT  -146 114 -19.6 -43.4 1,373  
Pre-tax profit (PTP)  -55.6 233.2 -1,948.9 38.5 1,522.0  
Net earnings  -43.4 181.9 -1,520.1 29.9 1,187.2  
Pre-tax profit without non-rec. items  -55.6 233 -1,949 38.5 1,522  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Tangible assets total  587 564 541 519 496  
Shareholders equity total  8,593 8,775 7,254 7,284 2,771  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 2.4  
Balance sheet total (assets)  8,729 8,991 7,469 7,375 2,896  
Net Debt  -319 -512 -471 -249 -765  
 
See the entire balance sheet

Volume 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  200 450 335 236 1,456  
Gross profit growth  -44.7% 125.7% -25.7% -29.4% 516.3%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  8,729 8,991 7,469 7,375 2,896  
Balance sheet change%  -2.6% 3.0% -16.9% -1.3% -60.7%  
Added value  -115.4 139.5 3.0 -20.8 1,395.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -54 -48 -45 -45 -45  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 -1.0 -2.0 1.0  

Profitability 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -73.4% 25.4% -5.9% -18.4% 94.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -0.6% 2.7% 0.8% 0.6% 29.6%  
ROI %  -0.6% 2.7% 0.9% 0.6% 30.3%  
ROE %  -0.5% 2.1% -19.0% 0.4% 23.6%  

Solidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Equity ratio %  98.4% 97.6% 97.1% 98.8% 95.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  276.2% -367.2% -15,456.7% 1,199.3% -54.8%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 25.8%  

Liquidity 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Quick Ratio  56.4 36.6 29.6 69.9 16.0  
Current Ratio  59.8 39.0 32.2 75.5 19.3  
Cash and cash equivalent  318.7 512.4 471.0 248.8 767.2  

Capital use efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  8,005.8 8,210.4 6,712.9 6,765.5 1,042.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/4
2020
2021/4
2021
2022/4
2022
2023/4
2023
2024/4
Net sales / employee  0 0 0 0 0  
Added value / employee  -115 140 3 -21 1,396  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -115 140 3 -21 1,396  
EBIT / employee  -146 114 -20 -43 1,373  
Net earnings / employee  -43 182 -1,520 30 1,187